Correlation analysis of serum obestatin expression with insulin resistance in childhood obesity

M Y Zhang, F Li, J P Wang1

  • 1Department of Pediatrics, Shaoxing Second Hospital, Shaoxing, , China jupingwangd@sina.com.

Insights

Low obestatin levels are linked to childhood obesity and insulin resistance. This study found lower obestatin in obese children, suggesting its role in metabolic health.

Area of Science:

  • Endocrinology
  • Pediatrics
  • Metabolic Health

Background:

  • Childhood obesity is a significant public health issue with long-term health implications.
  • Obestatin, a hormone involved in appetite regulation, has a known negative correlation with basal insulin levels.
  • Understanding factors contributing to insulin resistance in children is crucial for effective interventions.

Purpose of the Study:

  • To investigate the association between obestatin levels and insulin resistance in children with simple obesity.
  • To compare obestatin levels and metabolic markers between obese children and healthy controls.

Main Methods:

  • Recruited 54 children with simple obesity and 57 healthy controls.
  • Measured serum insulin, fasting blood glucose, lipids (cholesterol, triglyceride, LDL, HDL), and leptin.
  • Quantified serum obestatin levels using enzyme-linked immunosorbent assay (ELISA).

Main Results:

  • Obese children had significantly higher BMI, waist-hip ratio, insulin, total cholesterol, triglyceride, LDL, and leptin levels compared to controls.
  • Serum obestatin levels were significantly lower in the obese group (P < 0.001).
  • Insulin resistance index positively correlated with BMI, waist-hip ratio, and triglyceride levels.

Conclusions:

  • Obestatin levels are negatively correlated with fasting insulin and leptin in obese children.
  • Lower obestatin levels are associated with increased insulin resistance in childhood obesity.
  • Obestatin may play a role in the pathophysiology of insulin resistance in pediatric obesity.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
326
Coefficient of Correlation01:12

Coefficient of Correlation

The correlation coefficient, r, developed by Karl Pearson in the early 1900s, is numerical and provides a measure of strength and direction of the linear association between the independent variable x and the dependent variable y.
If you suspect a linear relationship between x and y, then r can measure how strong the linear relationship is.
What the VALUE of r tells us:
The value of r is always between –1 and +1: –1 ≤ r ≤ 1.
The size of the correlation r indicates the...
8.9K